Antimicrobial compositions comprising iodopropargyl compounds and isothiazolones

Abstract: A synergistic antimicrobial composition comprising 2-alkyl-3-isothiazolones, preferably 4,5-dichloro-2-n-octyl-3-isothiazolone or 2-n-octyl-3-isothiazolone, and certain iodopropargyl compounds, in a ratio to each other which exhibits synergism is disclosed.

Description: The present invention relates to antimicrobial compositions and methods of controlling microbes. The presence of microbes in various aqueous systems such as latices, paints, coatings, cooling water systems, decorative ponds and the like, can cause deterioration or disfigurement of these systems. For example, painted surfaces may be disfigured by the unsightly buildup of microbes, thus detracting from the overall aesthetics of the painted article; cooling towers may lose efficiency due to the buildup of microbes on surfaces, thus reducing the heat transfer capabilities of the tower. It is conventional to practice methods which inhibit the microbial deterioration of such systems by incorporating a variety of additives or combination of additives that are characterized by having antimicrobial activity. A wide variety of materials have been used to control microbes in different environments, some of which are: chlorine/bromine compounds, glutaraldehyde, isothiazolones, organotin formulations, copper salts, quaternary ammonium compounds (SD Strauss and PR Puckorius in J. Power , S1, June 1984), and triazines. Each has deficiencies related to toxicity, pH and temperature sensitivity, limited effectiveness, chemical stability, and/or compatibility. Based on the aforementioned performance deficiencies of conventional antimicrobial compounds there is a need for more effective antimicrobial agents that can be used at lower dosage rates, thus being more cost effective for the end user, reducing the pollution load on the affected environmental systems, and reducing the side effects to nearby non-target organisms, such as fish, useful crops, etc. Accordingly the present invention provides in one aspect a composition comprising a 2-alkyl-3-isothiazolone of the formula wherein Y is a (C₅-C₁₂)alkyl or a (C₅-C₈)cycloalkyl, and X and X¹ are each independently hydrogen, halogen, or (C₁-C₄)alkyl; and an iodopropargyl compound, either of the formula wherein A is hydrogen, (C₁-C₄)alkyl, aryl optionally substituted with one or more of halo, Me, MeO, CF₃ or NO₂, or a heterocycle, and Y² and Z are each independently O, S, or N-R⁴, where R⁴ is hydrogen, or alkyl, alkenyl, alkynyl, phenyl or a heterocycle each optionally substituted with halo, (C₁-C₄)alkyl, (C₁-C₄)alkoxy, cyano or nitro, the isothiazolone and iodopropargyl compound being present in a ratio producing a synergistic effect. Usually the compositions of the invention also contain an inert, agronomically or pharmaceutically acceptable carrier, or a solvent. In another aspect the invention provides a method for preventing or inhibiting the growth of bacteria, fungi or algae in a locus susceptible or subject to contamination thereby, comprising incorporating onto or into the locus, in an amount effective to adversely affect said growth, a composition as defined above. The invention also comprises the use of such a composition as a microbicide. Another important utility is in imparting microbial resistance to a coating or an impregnant composition by incorporation of the composition of the invention in the coating or impregnant, preferably at a concentration of about 0.1 ppm to about 2 percent, more preferably at a concentration of about 1 ppm to 1 percent, and most preferably at a concentration of about 10 to 4000 ppm. Algae-resistant coating or impregnant compositions provided by the invention preferably comprise about 0.1 ppm to about 2 percent of the antimicrobial composition, more preferably about 10 to 4000 ppm. In a marine antifoulant composition, on the other hand, the antimicrobial composition of the invention comprises about 1 to 10 percent of the antifoulant composition. In a therapeutic pharmaceutical formulation, e.g., lotion, cream, ointment or topical treatment; in the treatment of metal working fluids; and in the protection of fabric, leather, paper or wood materials, the microbicidal composition is added at a concentration of from about 0.1 ppm to about 2 percent by weight. In aqueous media, the microbicidal composition comprises from about 0.1 ppm to about 1 percent of the aqueous system depending on the specific end use; for example, in cooling water tower applications and with pulp or paper manufacturing processes, the microbicidal composition is added at a concentration from about 0.1 to about 1000 ppm by weight. In cosmetic formulations, e.g., face or hand creams, toiletries, etc.; and in the treatment of fuel systems, e.g., jet fuel, gasoline, heating oil, etc., the microbicidal composition is added at a concentration of from about 0.1 ppm to about 1 percent by weight. The microbial resistant compositions can also be used in construction products such as stucco, roof mastics, wall mastics, and masonry coatings for algae protection; in clear finishes and coatings to protect underlying substrates from algae; for algae control in aquaculture, including aquaria, fish hatcheries, shrimp ponds, finfish ponds, mollusc and crustacean cultivation; for algae control in recreational and decorative bodies of water such as swimming pools, lakes, fountains and decorative ponds; for algae control in bodies of water for industrial or municipal use, such as settling or separation ponds, waste treatment ponds, and water reservoirs; for algae control in hydroponic farming; for algae control in processing and manufacture of pulp and paper products; for inclusion in plastics or in coatings for plastics to protect against algae; and in plastics or coatings for plastics for swimming pool liners. We prefer antimicrobial compositions wherein the weight ratio of isothiazolone to iodopropargyl compound is about 0.1/100 to about 100/0.1. A particularly preferred ratio range is from about 1/20 to about 20/1 by weight. The following examples represent just a few of the many uses and compounds of the invention. They are intended to be illustrative but not limiting. Various modifications, alternatives, and improvements should become apparent to those skilled in the art. EXAMPLES A. General Procedure MIC values represent the Minimum Inhibitory Concentration. This is defined as the lowest level of compound required to completely inhibit (repress) the growth of a given organism. A synergistic effect is defined as the response of two variables which is greater than the sum of both parts alone. Synergy was determined from combination studies with two compounds by the method of calculation described by F. C. Kull, P. C. Eisman, H. D. Sylwestrowicz and R. K. Mayer, Applied Microbiology 9 ,538 (1961): where: Q A = quantity of compound A, acting alone, producing an end point (MIC) Q a = quantity of compound A, in mixture, producing an end point (MIC) Q B = quantity of compound B, acting alone, producing an end point (MIC) Q b = quantity of compound B, in mixture, producing an end point (MIC) The following SI values may be attained: SI > 1 represents antagonistic effect, SI = 1 represents additive effect, SI < 1 represents synergy. Efficacy studies were conducted on a variety of microorganisms with iodopropargyl compounds and isothiazolone mixtures. The MIC studies were conducted using microtiter plate assays. In this method, a wide range of concentrations was tested by preparing two-fold serial dilutions of the compound in 96-well plastic microtiter plates. All liquid media transfers were performed with calibrated single or multichannel digital pipetters. Stock solutions of compounds were prepared in appropriate solvents and dispensed to the growth medium. All subsequent dilutions in plates were made using the desired growth medium; total volume of liquid in each well was 100 µl. Each plate contained a concentration of both compounds made by serially titrating equal volumes of liquids in two directions in the microtiter plate. Each plate contained a control row for each combination (one component only), hence, the individual compound MIC values were also determined. B. Isothiazolone Structure Isothiazolones included in the examples are designated as follows: 1) Isothiazolone A: 4,5-dichloro-2- n -octyl-3-isothiazolone 2) Isothiazolone B: 2- n -octyl-3-isothiazolone C. Iodopropargyl Compounds Iodopropargyl compounds included in the examples are designated as follows: 1) Iodopropargyl A: 1-(3-iodopropargyl)-4-(4-chlorophenyl)-1,2,4-triazolin-5-one 2) Iodopropargyl B: 4-(3-iodopropargyl)-2-propyl-1,3,4-oxadiazolin-5-one EXAMPLE 1 Using a pure culture of Aureobasidium pullulans , various combinations of Iodopropargyl B and Isothiazolone B were subjected to MIC determinations in mycophil broth (pH = 5). Compound A is Isothiazolone B and Compound B is Iodopropargyl B. Qa Qb Qa/Qb SI 0 2.5 (Q B ) - 1.0 0.31 1.25 20/80 0.62 0.62 1.25 33/67 0.75 1.25 0.62 67/33 0.75 1.25 0.31 80/20 0.62 2.5 (Q A ) 0 - 1.0 EXAMPLE 2 Using a pure culture of Aureobasidium pullulans , various combinations of Iodopropargyl A and Isothiazolone B were subjected to MIC determinations in mycophil broth (pH = 5). Compound A is Isothiazolone B and Compound B is Iodopropargyl A. Qa Qb Qa/Qb SI 0 2.5 (Q B ) - 1.0 0.31 1.25 20/80 0.62 0.62 1.25 33/67 0.75 0.62 0.62 50/50 0.50 1.25 0.31 80/20 0.62 1.25 0.16 89/11 0.56 1.25 0.08 94/6 0.53 2.5 (Q A ) 0 - 1.0 EXAMPLE 3 Using a pure culture of Aureobasidium pullulans , various combinations of Iodopropargyl A and Isothiazolone A were subjected to MIC determinations in mycophil broth (pH = 5). Compound A is Isothiazolone A and Compound B is Iodopropargyl A. Qa Qb Qa/Qb SI 0 0.62 (Q B ) - 1.0 0.16 0.31 33/67 0.56 0.31 0.31 50/50 0.62 0.31 0.16 67/33 0.37 0.62 0.31 67/33 0.75 0.62 0.16 80/20 0.50 0.62 0.08 89/11 0.37 1.25 0.16 89/11 0.75 1.25 0.08 93/7 0.62 2.5 (Q A ) 0 - 1.0 EXAMPLE 4 Using a pure culture of Aureobasidium pullulans , various combinations of Iodopropargyl A and Isothiazolone A were subjected to MIC determinations in mycophil broth (pH = 7). Compound A is Isothiazolone A and Compound B is Iodopropargyl A. Qa Qb Qa/Qb SI 0 3.1 (Q B ) - 1.0 0.16 1.56 9/91 0.56 0.31 1.56 17/83 0.62 0.31 0.78 29/71 0.37 0.62 1.56 29/71 0.75 0.62 0.78 45/55 0.50 0.62 0.39 62/38 0.37 1.25 0.78 62/38 0.75 1.25 0.39 76/24 0.62 1.25 0.2 86/14 0.56 2.5 (Q A ) - - 1.0 EXAMPLE 5 Using a pure culture of Aureobasidium pullulans , various combinations of Iodopropargyl B and Isothiazolone A were subjected to MIC determinations in mycophil broth (pH = 5). Compound A is Isothiazolone A and Compound B is Iodopropargyl B. Qa Qb Qa/Qb SI 0 2.5 (Q B ) - 1.0 0.16 1.25 11/89 0.62 0.16 0.62 20/80 0.37 0.31 1.25 20/80 0.75 0.31 0.62 33/67 0.50 0.31 0.31 50/50 0.75 0.62 0.62 50/50 0.75 0.62 0.31 67/33 0.62 1.25 (Q A ) 0 - 1.0 EXAMPLE 6 Using a pure culture of Aureobasidium pullulans , various combinations of Iodopropargyl B and Isothiazolone A were subjected to MIC determinations in mycophil broth (pH = 7). Compound A is Isothiazolone A and Compound B is Iodopropargyl B. Qa Qb Qa/Qb SI 0 3.1 (Q B ) - 1.0 0.16 1.56 9/91 0.56 0.31 1.56 17/83 0.62 0.31 0.78 28/72 0.37 0.62 1.56 28/72 0.75 0.62 0.78 44/56 0.50 0.62 0.39 62/38 0.37 1.25 0.78 62/38 0.75 1.25 0.39 76/24 0.62 1.25 0.2 86/14 0.56 2.5 (Q A ) 0 - 1.0

Claims: Composition comprising a 2-alkyl-3-isothiazolone of the formula wherein Y is a (C₅-C₁₂)alkyl or a (C₅-C₈)cycloalkyl, and X and X¹ are each independently hydrogen, halogen, or (C₁-C₄)alkyl; and an iodopropargyl compound, either of the formula wherein A is hydrogen, (C₁-C₄)alkyl, aryl optionally substituted with one or more of halo, Me, MeO, CF₃ or NO₂, or a heterocycle, and Y² and Z are each independently O, S, or N-R⁴, where R⁴ is hydrogen, or alkyl, alkenyl, alkynyl, phenyl or a heterocycle each optionally substituted with halo, (C₁-C₄)alkyl, (C₁-C₄)alkoxy, cyano or nitro, the isothiazolone and iodopropargyl compound being present in a ratio producing a synergistic effect. Composition according to claim 1 wherein the iodopropargyl compound is 1-(3-iodopropargyl)-4-(4-chlorophenyl)-1,2,4-triazolin-5-one, 4-(3-iodopropargyl)-2-propyl-1,3,4-oxadiazolin-5-one. Composition according to claim 1 or 2 wherein said isothiazolone is 4,5-dichloro-2-n-octyl-3-isothiazolone or 2-n-octyl-3-isothiazolone. Composition according to any preceding claim wherein the ratio of isothiazolone to iodopropargyl compound is from 0.1:100 to 100:0.1, preferably from 1:20 to 20:1. Composition according to any preceding claim, further comprising an inert, agronomically or pharmaceutically acceptable carrier, or a solvent. Composition according to claim 5, wherein the combination of isothiazolone and iodopropargyl compound is present in an amount of from 0.1 ppm to 10 per cent by weight of the composition. A method for preventing or inhibiting the growth of bacteria, fungi or algae in a locus susceptible or subject to contamination thereby, comprising incorporating onto or into the locus, in an amount effective to adversely affect said growth, a composition according to any preceding claim. Method according to claim 7 wherein the locus is an aqueous medium, fuel system or cosmetic formulation and the composition is used in an amount of from 0.1 ppm to 1 percent by weight, or a coating or impregnant composition, a metal working fluid, fabric, leather, paper or wood and the composition of claim 1 is used in an amount of from 0.1 ppm to 2 percent by weight, or a marine antifoulant composition and the composition is used in an amount of from 1 to 10 percent by weight, or a pulp or paper manufacturing process or cooling tower water and the composition is used in an amount of from 0.1 to 1000 ppm by weight. Use of a composition according to any one of claims 1 to 6 as a microbicide.

Inventors: MEHTA RAJ J, SHERBA SAMUEL EUGENE, MEHTA, RAJ J., SHERBA, SAMUEL EUGENE
Applicants: ROHM & HAAS, ROHM AND HAAS COMPANY
Application year: 1992
Main classification: A01N43
IPC codes: A01N43, A01N37